S'abonner

The esophageal biopsy “pull” sign: a highly specific and treatment-responsive endoscopic finding in eosinophilic esophagitis (with video) - 02/06/16

Doi : 10.1016/j.gie.2015.05.046 
Evan S. Dellon, MD, MPH 1, 2, , Jessica H. Gebhart, MSHS 1, Leana L. Higgins, MS 1, Kelly E. Hathorn, BS 1, John T. Woosley, MD, PhD 3, Nicholas J. Shaheen, MD, MPH 1, 2
1 Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA 
2 Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA 
3 Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA 

Reprint requests: Evan S. Dellon, MD, CB#7080, Bioinformatics Building, 130 Mason Farm Rd., UNC-CH, Chapel Hill, NC 27599-7080.

Abstract

Background and Aims

Esophageal biopsy specimens from patients with eosinophilic esophagitis (EoE) can feel firm, with resistance felt when pulling the forceps to obtain the tissue sample. We aimed to assess the diagnostic utility of the esophageal biopsy “pull” sign and determine its histologic associations and response to treatment.

Methods

This was a prospective cohort study of adults undergoing outpatient upper endoscopy. Cases of EoE were diagnosed per consensus guidelines, and patients were subsequently treated with either topical steroids or dietary elimination. Control subjects were individuals who did not have EoE. The frequency of the esophageal biopsy “pull” sign was assessed in EoE patients and controls, and diagnostic metrics were calculated. The “pull” sign was also reassessed in patients after therapy.

Results

A total of 83 EoE patients and 121 control subjects were included. Sixty-three EoE patients (76%) were “pull” sign positive compared with just 2 control subjects (2%; P < .001), corresponding to a sensitivity and specificity of 76% and 98%, positive and negative predictive values of 97% and 86%, and positive and negative likelihood ratios of 45.9 and 0.245, respectively. The “pull” sign was the strongest endoscopic predictor of EoE case status at baseline and was less frequent after successful treatment (20% vs 79%; P < .001).

Conclusions

The “pull” sign is highly specific for EoE and is rarely seen in non-EoE control subjects. In patients with EoE who respond to treatment, the “pull” sign often resolves. The “pull” sign may be a simple and easily obtained measure of esophageal remodeling.

Le texte complet de cet article est disponible en PDF.

Abbreviations : CI, EoE, eos/hpf, LR, OR, PPI, PPI-REE


Plan


 DISCLOSURE: This work was supported, in part, by NIH Awards K23 DK090073 (E.S.D.) and K24DK100548 (N.J.S.), and uses resources from the UNC Center for GI Biology and Disease (P30 DK34987). All authors disclosed no financial relationships relevant to this article.
 If you would like to chat with an author of this article, you may contact Dr Dellon at edellon@med.unc.edu.


© 2016  American Society for Gastrointestinal Endoscopy. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 83 - N° 1

P. 92-100 - janvier 2016 Retour au numéro
Article précédent Article précédent
  • A “deeper” look at subsquamous structures beneath the neosquamous epithelium after Barrett’s esophagus endotherapy
  • Prasad G. Iyer
| Article suivant Article suivant
  • Randomized controlled trial of self-directed versus in-classroom teaching of narrow-band imaging for diagnosis of Barrett’s esophagus–associated neoplasia
  • Claire Daly, Prashanth Vennalaganti, Samad Soudagar, Ben Hornung, Prateek Sharma, Neil Gupta

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.